Vinorelbine potently induces placental cell death, does not harm fertility and is a potential treatment for ectopic pregnancy
Roxanne is a research scientist with a focus on using big health data to improve maternal and neonatal outcomes globally. Roxanne completed her PhD within the Translational Obstetrics Group at the Mercy Hospital for Women. During her PhD, working with her supervisors, Professor Stephen Tong and Dr Tu’uhevaha Kaitu’u-Lino, Roxanne identified a new medical therapeutic for ectopic pregnancy, as well as uncovering an important cellular mechanism involved in the release of factors that cause preeclampsia. Roxanne is hopeful that both of these discoveries may help treat women with these pregnancy complications.
Since completing her PhD, Roxanne has developed a keen interest in perinatal epidemiology and is currently completing a Masters of Epidemiology whilst undertaking her postdoctoral research. Her research focus is global maternal health, investigating rare pregnancy complication in low resource settings as well as using world-class health databases in high-resource settings to investigate the potential benefit or harm of medical therapeutics used throughout pregnancy. Roxanne hopes these studies will help inform and improve clinical care globally.